Worth Seeing!
Check why we had a strong conviction on IEX, Tata Power, Titan, Divis Lab, Persistent & Birlasoft Get Report Instantly Get Report Instantly
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 74005.94
88.91 (0.12%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Sequent Scientific Ltd.
2,898
(Small Cap)
116.35
(-0.68%)
N/A
4.55
10.88
-288.40
Q V PT
2
Solara Active Pharma Sciences Ltd.
2,330
(Small Cap)
481.75
(0.11%)
N/A
1.41
22.61
-221.22
Q V PT
3
Shilpa Medicare Ltd.
4,894
(Small Cap)
499.30
(-4.38%)
N/A
2.23
5.89
-183.46
Q V PT
4
Suven Life Sciences Ltd.
2,182
(Small Cap)
100.40
(1.26%)
N/A
2.56
-53.54
-163.87
Q V PT
5
Strides Pharma Science Ltd.
7,992
(Small Cap)
871.45
(0.21%)
107.95
2.27
4.76
-151.49
Q V PT
6
SMS Pharmaceuticals Ltd.
1,750
(Small Cap)
207
(0.15%)
41.89
3.31
2.34
-48.56
Q V+ PT
7
Sastasundar Ventures Ltd.
919
(Small Cap)
298.25
(2.35%)
N/A
3.4
-100.00
-43.78
Q V PT
8
Glenmark Pharmaceuticals Ltd.
28,770
(Small Cap)
1,043
(2.30%)
N/A
3.2
7.44
-31.19
Q V PT
9
Jubilant Pharmova Ltd.
11,466
(Small Cap)
716.20
(-0.49%)
N/A
4.9
-24.52
-28.13
Q V+ PT
10
Dishman Carbogen Amcis Ltd.
3,035
(Small Cap)
197
(-0.56%)
N/A
0.54
7.32
-23.69
Q V PT
11
Aurobindo Pharma Ltd.
68,194
(Mid Cap)
1,203.90
(3.44%)
34.57
3.52
4.49
-7.93
Q V PT
12
Thyrocare Technologies Ltd.
3,437
(Small Cap)
646.75
(-0.35%)
48.59
6.53
8.13
-7.14
Q V PT
13
Hikal Ltd.
3,675
(Small Cap)
299.75
(0.57%)
52.3
3.06
9.31
-0.88
Q V PT
14
Zydus Lifesciences Ltd.
1,05,846
(Large Cap)
1,104.45
(5.00%)
34.13
5.39
7.68
-0.07
Q V PT
15
Innova Captab Ltd.
2,872
(Small Cap)
516.10
(2.84%)
48.46
3.06
0.00
0.00
Q V+ PT
16
Unichem Laboratories Ltd.
3,907
(Small Cap)
561
(3.23%)
N/A
1.59
9.99
0.00
Q V PT
17
Max Healthcare Institute Ltd.
81,699
(Mid Cap)
847.75
(0.85%)
78
10.13
21.42
0.00
Q V+ PT
18
Aarti Pharmalabs Ltd.
5,564
(Small Cap)
608.50
(-0.90%)
27.39
3.39
0.00
0.00
Q V+ PT
19
Tarsons Products Ltd.
2,335
(Small Cap)
440
(0.25%)
42.28
3.89
0.00
0.00
Q V PT
20
Piramal Pharma Ltd.
19,824
(Small Cap)
149.30
(-0.37%)
50.44
2.94
0.00
0.00
Q V PT
21
Krishna Institute of Medical Sciences Ltd
15,141
(Small Cap)
1,955.75
(3.37%)
58.95
8.49
12.50
0.00
Q V PT
22
Panacea Biotec Ltd.
838
(Small Cap)
136.50
(0.18%)
N/A
2.52
-14.85
0.00
Q V PT
23
Jagsonpal Pharmaceuticals Ltd.
945
(Small Cap)
360.85
(0.97%)
36.48
5
13.35
0.00
Q V+ PT
24
Wockhardt Ltd.
8,317
(Small Cap)
549.60
(0.59%)
N/A
2.38
-7.60
0.00
Q V PT
25
Blue Jet Healthcare Ltd.
6,285
(Small Cap)
369
(1.85%)
39.53
3.85
0.00
0.00
Q V+ PT
26
IOL Chemicals And Pharmaceuticals Ltd.
2,196
(Small Cap)
378.35
(1.12%)
16.27
1.36
0.00
0.00
Q V+ PT
27
Vijaya Diagnostic Centre Ltd.
7,948
(Small Cap)
800
(3.19%)
67.72
12.24
0.00
0.00
Q V+ PT
28
Yatharth Hospital & Trauma Care Services Ltd.
3,831
(Small Cap)
449.40
(0.71%)
58.76
4.65
0.00
0.00
Q V+ PT
29
Concord Biotech Ltd.
14,976
(Small Cap)
1,493.90
(4.36%)
63.6
10.69
0.00
0.00
Q V PT
30
Suven Pharmaceuticals Ltd.
16,352
(Small Cap)
645
(0.41%)
44.3
8.29
0.00
0.00
Q V PT
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Sigachi Industries
69.115%
Zydus Lifesciences
1,104.455%
Concord Biotech
1,493.904.36%
RainbowChildrenS Med
1,3893.64%
Aurobindo Pharma
1,203.903.44%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Shilpa Medicare
499.30-4.38%
Caplin Point Lab
1,313.05-1.90%
HealthcareGlobal
359.15-1.41%
Marksans Pharma
166.90-1.33%
Gland Pharma
1,768.35-1.31%
View More

News about Top Pharma Companies in India

IOL Chemicals and Pharmaceuticals informs about loss of share certificate

Pursuant to Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that it has received letter regarding loss of share certificate and requesting the Company for issue of duplicate share certificate, from shareholder, as details enclosed.

The above information is a part of company’s filings submitted to BSE.


18 May, 2024

Zydus Lifesciences touches roof on reporting 3-fold jump in Q4 consolidated net profit

Total consolidated income of the company increased by 12.71% at Rs 5690.20 crore for Q4FY24
18 May, 2024

Zydus Lifesciences reports 3- fold jump in Q4 consolidated net profit

Total consolidated income of the company increased by 12.71% at Rs 5690.20 crore for Q4FY24
17 May, 2024

Saudi Food and Drug Authority completes inspection at Concord Biotech’s manufacturing unit II

In February 2024, Ministry of Health Pharmacy and Poisons Board, Republic of Kenya had completed inspection at Concord Biotech’s Unit II
17 May, 2024

Zydus Lifesciences - Quaterly Results

A decent increase of about 29.20% in the sales to Rs. 33324.00 millions was observed for the quarter ended March 2024. The sales figure stood at Rs. 25793.00 millions during the year-ago period.Net Profit for the quarter ended March 2024 zoomed to 186.37% from Rs. 4907.00 millions to Rs. 14052.00  millions.Operating profit for the quarter ended March 2024 rose to 19303.00 millions as compared to 10237.00 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 33324.00 25793.00 29.20 108187.00 87316.00 23.90 108187.00 87316.00 23.90
Other Income 3688.00 2512.00 46.82 11595.00 8219.00 41.08 11595.00 8219.00 41.08
PBIDT 19303.00 10237.00 88.56 51435.00 30028.00 71.29 51435.00 30028.00 71.29
Interest 1062.00 850.00 24.94 3907.00 2782.00 40.44 3907.00 2782.00 40.44
PBDT 18155.00 7349.00 147.04 47442.00 25208.00 88.20 47442.00 25208.00 88.20
Depreciation 1306.00 1199.00 8.92 5044.00 4886.00 3.23 5044.00 4886.00 3.23
PBT 16849.00 6150.00 173.97 42398.00 20322.00 108.63 42398.00 20322.00 108.63
TAX 2797.00 1243.00 125.02 7983.00 5030.00 58.71 7983.00 5030.00 58.71
Deferred Tax -1278.00 -53.00 2311.32 -1360.00 412.00 -430.10 -1360.00 412.00 -430.10
PAT 14052.00 4907.00 186.37 34415.00 15292.00 125.05 34415.00 15292.00 125.05
Equity 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59
PBIDTM(%) 57.93 39.69 45.95 47.54 34.39 38.25 47.54 34.39 38.25
17 May, 2024

Krishna Institute of Medical Sciences informs about newspaper publication

Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that it enclosed a copy of the newspaper publication on the audited (Standalone and Consolidated) financial results of the company for the quarter and financial year ended 31st March 2024 published on 17th May 2024 in Financial Express (English) and Navatelangana (Telugu). The said publication may also be accessed on the website of the company: https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015/ Newspaper advertisements.

The above information is a part of company’s filings submitted to BSE.

17 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Sequent Scientific Ltd. 2,898 Crore
2 Solara Active Pharma Sciences Ltd. 2,330 Crore
3 Shilpa Medicare Ltd. 4,894 Crore
4 Suven Life Sciences Ltd. 2,182 Crore
5 Strides Pharma Science Ltd. 7,992 Crore
6 SMS Pharmaceuticals Ltd. 1,750 Crore
7 Sastasundar Ventures Ltd. 919 Crore
8 Glenmark Pharmaceuticals Ltd. 28,770 Crore
9 Jubilant Pharmova Ltd. 11,466 Crore
10 Dishman Carbogen Amcis Ltd. 3,035 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,821 20,399 37.13 18.82 23.83 51.69
Abbott India Ltd. (M) Very Good 26,618 56,290 46.86 15.22 31.83 31.69
Laurus Labs Ltd. (S) Very Good 443.6 23,712 147.7 5.77 32.44 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,813 96,742 17.34 3.42 10.95 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,699 91,321 61.13 12.77 29.30 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Lupin Ltd. (M) Somewhat Good 1,662 75,313 111.5
Zydus Lifesciences Ltd. (L) Very Good 1,104 1,05,846 102.6
Ipca Laboratories Ltd. (M) Very Good 1,311 33,049 90.39
Aurobindo Pharma Ltd. (M) Very Good 1,204 68,194 87.84
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,306 85.03
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 443.6 23,712 147.7 5.77 32.44 24.05
Granules India Ltd. (S) Somewhat Good 405.5 9,738 22.34 3.13 13.09 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,306 55.92 10.07 33.04 18.11
Gland Pharma Ltd. (M) Very Good 1,768 29,512 36.84 3.40 21.00 17.42
Mankind Pharma Ltd. (L) Very Good 2,115 83,873 46.00 8.71 32.07 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 443.6 23,712 147.7 5.77 32.44 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,813 96,742 17.34 3.42 10.95 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,306 55.92 10.07 33.04 31.92
Biocon Ltd. (M) Somewhat Good 304.9 36,720 307.8 3.37 83.77 31.80
Granules India Ltd. (S) Somewhat Good 405.5 9,738 22.34 3.13 13.09 31.51
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.